To assess if even a single treatment of ispinesib can impact tumor cell viability, we evaluated for changes in apoptosis, via immunofluorescence, to the apoptotic marker cleaved-Caspase-3 (cl-Caspase-3) for both the whole tumor, and comparing the tumor rim to the tumor core (Figure 2d–f). Here, CASP3 is linked to neoplasm.